Skip to main content
. 2015 Jul 20;6(30):29324–29334. doi: 10.18632/oncotarget.4979

Figure 5.

Figure 5

A. Patients with low ANO9 expression (n = 37) showed a significantly poorer prognisis than those with high ANO9 expression (n = 27; P < 0.05; log-rank test). B. Patients with low ANO9 expression (n = 534) showed a significantly poorer prognosis than those with strong expression (n = 23) based on R2 applications.